Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes (vol 107, pg 1888, 2022)
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM